GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Cash And Cash Equivalents

DuChemBio Co (XKRX:176750) Cash And Cash Equivalents : ₩1,970 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co Cash And Cash Equivalents?

DuChemBio Co's quarterly cash and cash equivalents increased from Dec. 2021 (₩1,153.61 Mil) to Dec. 2022 (₩2,594.25 Mil) but then stayed the same from Dec. 2022 (₩2,594.25 Mil) to Dec. 2023 (₩1,969.71 Mil).

DuChemBio Co's annual cash and cash equivalents increased from Dec. 2021 (₩1,153.61 Mil) to Dec. 2022 (₩2,594.25 Mil) but then declined from Dec. 2022 (₩2,594.25 Mil) to Dec. 2023 (₩1,969.71 Mil).


DuChemBio Co Cash And Cash Equivalents Historical Data

The historical data trend for DuChemBio Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co Cash And Cash Equivalents Chart

DuChemBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial 1,092.66 858.99 1,153.61 2,594.25 1,969.71

DuChemBio Co Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents Get a 7-Day Free Trial 1,092.66 858.99 1,153.61 2,594.25 1,969.71

DuChemBio Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


DuChemBio Co  (XKRX:176750) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


DuChemBio Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of DuChemBio Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


DuChemBio Co (XKRX:176750) Business Description

Traded in Other Exchanges
N/A
Address
Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3
DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines